The weekly litigation news digest is live. Subscribe now

IP Verse

Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive Therapy

Patent No. EP4219687 (titled "Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive Therapy") was filed by Juno Therapeutics on Apr 23, 2015. The application was issued on Aug 14, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AMMELBURGMay 14, 2025FISH & RICHARDSON PC
ARROWHOUSEMay 14, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
POHLMANOct 29, 2024POHLMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4219687

JUNO THERAPEUTICS
Application Number
EP23164036A
Filing Date
Apr 23, 2015
Status
Granted And Under Opposition
Jul 12, 2024
Publication Date
Aug 14, 2024
External Links
Slate, EP4219687B1, Google Patents